HONG WEI ASIA (08191) announced its interim results, with a net profit of HKD 15.815 million, turning around from a loss in the same period last year.
Hong Wei Asia (08191) announced its mid-term results for 2026, with revenue of HKD 40.954 million, a year-on-year decrease of 17.91%; net profit of HKD 15.815 million, turning from loss to profit year-on-year; earnings per share of HKD 0.2171.
HONG WEI ASIA (08191) announced its interim results for 2026, reporting revenue of HKD 40.954 million, a decrease of 17.91% year-on-year; net profit of HKD 15.815 million, turning from a loss to a profit year-on-year; and earnings per share of HKD 0.2171.
The announcement stated that the revenue decline was primarily due to the scheduled production stoppage and ongoing technological upgrades in mid-2026, which temporarily affected production capacity and led to a decrease in particleboard sales. The turnaround from a loss to a profit was mainly attributed to an increase in gross profit and a reduction in administrative expenses, as well as the recognition of income from the termination of outstanding promissory notes during the period.
Related Articles

After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).
After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).

RECOMMEND





